males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important
forty diabetic men (type 2) who complain presence of low vitamin D and impotence will be divided to group number I and group number II. Both groups will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.
Cairo University
Dokki, Giza Governorate, Egypt
RECRUITINGinternational index of erectile function
questionnaire used to assess impotence
Time frame: it will be measured after 12 weeks
glycated hemoglubin
it will be used to assess blood glcuose
Time frame: It will be measured after 12 weeks
fasting blood glcuose
it will be used to assess blood glcuose in serum
Time frame: It will be measured after 12 weeks
body mass index
it will be measured on empty stomach and bladder
Time frame: It will be measured after 12 weeks
wasit circumference
it will be measured at umbilicus level
Time frame: it will be measured after 12 weeks
high density lipoprotein
it will be measured in serum
Time frame: It will be measured after 12 weeks
low density lipoprotein
it will be measured in serum
Time frame: It will be measured after 12 weeks
triglycerides
it will be assessed in serum
Time frame: It will be measured after 12 weeks
cholesterol
it will be assessed in serum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: It will be measured after 12 weeks
25-hydroxyvitamin D
it will be assessed in serum as a metabolite of vitamin D
Time frame: It will be measured after 12 weeks